Personal care giant Procter & Gamble has filed a lawsuit alleging competitor Colgate-Palmolive has violated the consumer law by falsely claiming that its whitening toothpaste can remove 10 years of stains.
Two law firms that filed competing shareholder class actions against construction giant Boral have asked the court to permanently stay the other’s proceeding, after the judge overseeing the matter said he might wait until the High Court’s ruling on the AMP class action beauty parade before deciding which class action should move forward.
Global animal health company Zoetis has told the lead applicants in a class action over horse vaccines to “put up or shut up” and produce evidence disclosing an alleged scientific link between the hendra virus vaccine and certain alleged adverse side effects.
The lead applicants in a class action against The Cosmetic Institute have added 11 cosmetic surgeons to the lawsuit, alleging they conducted breast augmentation surgery in an “incompetent” manner.
A referee has been appointed to examine the fees for the liquidators of stockbroker Halifax Investment Services, which collapsed in December 2018, trapping around $200 million in client funds.
More than 500 women from across the legal profession, including former judges, barristers, law firm partners and professors, have signed a letter urging the Attorney General to establish an independent body to deal with complaints against judges, following allegations of sexual harassment against former High Court Justice Dyson Heydon.
Former Liberal leader John Hewson has filed a defamation suit against Nine, claiming a report by A Current Affair about his insurance firm was gratuitous and “seriously dishonest”.
Maddens has once again been criticised for its non-compliant costs agreements, three months after receiving similar feedback from a Victoria Supreme Court judge overseeing the firm’s bushfire class actions.
A US-based aviation leasing company has launched proceedings against Virgin Australia and its administrators, seeking possession of aircraft engines and other parts in the first legal challenge to the conduct of the administration.
Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.